# Flash Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/flash-therapeutics-2

- Industry: Biotechnology
- Headquarters: Toulouse, France
- Website: www.flashtherapeutics.com
- Total disclosed funding: $18M
- Latest round: Series C (Sep 28, 2023)
- Investors on record: 3

## About

Founded in 2018 and based in Toulouse, France, Flash Therapeutics operates as a biotechnology company that offers gene therapy solutions. In May 2018, Vectalys SAS, a portfolio company of FJ Investissement, FaDiese, Galia Gestion, and Wiseed, merged with FlashCell, a portfolio company of Auriga Partners, to form Flash Therapeutics. In July 2021, Flash Therapeutics raised EUR 4 million in venture debt from Elaia Partners and TechLife Capital. As of 2023, the company is led by its CEO, Jérôme Bédier.

Flash Therapeutics provides gene therapy solutions and develops DNA and RNA lentiviral technologies for a wide range of clients, including pharmaceutical companies and biotech startups. The products and solutions offered by the company include LentiFlash®, which is a biological RNA delivery technology that develops multiple RNA species based on a bacteriophage-lentivirus chimera, which allows for the efficient and safe delivery of RNA into a wide range of cell types; Lentiviral Vectors, a DNA delivery technology; Vectalys, a manufacturing platform that develops regenerative medicine for cancer treatments; TheraLymph program, a therapy to restore lymphatic flow lymphedema; immunotherapy solutions; cell therapy solutions; and many more.

## Funding rounds

- Series C, Sep 28, 2023, $5.3M — Auriga Partners, TechLife Capital
- Series B, Oct 21, 2022 — Auriga Partners, TechLife Capital
- Series B, Feb 10, 2022, $3.5M — Auriga Partners, TechLife Capital
- Series B, Aug 5, 2021, $4.8M — Auriga Partners, TechLife Capital
- Series A, Apr 17, 2018, $4M — Auriga Partners, Galia Gestion

## Investors

- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series A, Series B, Series C
- Galia Gestion (https://capitalatlas.ai/funds/galia-gestion) — Series A
- TechLife Capital (https://capitalatlas.ai/funds/techlife-capital) — Series B, Series C